Management discussion of laws and regulations on human genetic resources in China: a scoping review

The governance of human genetic resources (HGRs) in China has evolved quickly, driven by national security concerns and the rapid expansion of the biotechnology sector. This review examines the resulting legal and policy framework, with a focus on cross-border data transfers and the management of informed consent. Employing a comprehensive search strategy integrated with bibliometric analysis, this study synthesized theoretical and methodological developments in Chinese HGRs management. Literature searches spanned publications across PubMed, Web of Science, CNKI, Wanfang database, official government websites, and Google. China’s HGRs management has evolved from principle-based legislation to specific administrative regulations. Informed consent has become stricter, with HGRs data classified as sensitive personal information requiring separate consent and the right to withdraw. This orientation enables strict oversight but also defines the limits within which informed consent can function. The number of international cooperation projects declined after 2023 due to refined regulatory classifications and multi-departmental collaboration. HGRs cross-border require a security review and filing by the National Health Commission, with sensitive data subject to additional assessment by the Cyberspace Administration. In contrast, general cross-border flows are primarily managed through security assessments or standard contract filings, with the negative list mechanism and risk-level exemptions being piloted in free trade zones. National security and data sovereignty remain central to China’s HGR governance, shaping strict oversight while limiting the practical reach of informed consent. Cross-border data sharing continues to face challenges, including regulatory discrepancies, privacy risks that extend beyond de-identification, and technical inconsistencies in data formats and annotation standards. Future progress requires enhanced transparency regarding data usage, improved technical interoperability aligned with domestic security requirements, and stronger international coordination through bilateral agreements.

Authors

Institutions

Publication Details

Journal
BMC Medical Ethics
Published
2026-04-14
DOI
https://doi.org/10.1186/s12910-026-01458-8
Primary Topic
International Maritime Law Issues
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Management discussion of laws and regulations on human genetic resources in China: a scoping review

Jian Huang, Yibo Liu, Yaodong Zhang, Qiuyu Sun et al.
BMC Medical Ethics
International Maritime Law Issues
article

Management discussion of laws and regulations on human genetic resources in China: a scoping review

Jian Huang, Yibo Liu, Yaodong Zhang, Qiuyu Sun, Kaijuan Wang
article en

Abstract

The governance of human genetic resources (HGRs) in China has evolved quickly, driven by national security concerns and the rapid expansion of the biotechnology sector. This review examines the resulting legal and policy framework, with a focus on cross-border data transfers and the management of informed consent. Employing a comprehensive search strategy integrated with bibliometric analysis, this study synthesized theoretical and methodological developments in Chinese HGRs management. Literature searches spanned publications across PubMed, Web of Science, CNKI, Wanfang database, official government websites, and Google. China’s HGRs management has evolved from principle-based legislation to specific administrative regulations. Informed consent has become stricter, with HGRs data classified as sensitive personal information requiring separate consent and the right to withdraw. This orientation enables strict oversight but also defines the limits within which informed consent can function. The number of international cooperation projects declined after 2023 due to refined regulatory classifications and multi-departmental collaboration. HGRs cross-border require a security review and filing by the National Health Commission, with sensitive data subject to additional assessment by the Cyberspace Administration. In contrast, general cross-border flows are primarily managed through security assessments or standard contract filings, with the negative list mechanism and risk-level exemptions being piloted in free trade zones. National security and data sovereignty remain central to China’s HGR governance, shaping strict oversight while limiting the practical reach of informed consent. Cross-border data sharing continues to face challenges, including regulatory discrepancies, privacy risks that extend beyond de-identification, and technical inconsistencies in data formats and annotation standards. Future progress requires enhanced transparency regarding data usage, improved technical interoperability aligned with domestic security requirements, and stronger international coordination through bilateral agreements.

BMC Medical Ethics
Zhengzhou University (CN), Zhengzhou Children's Hospital (CN), Henan Cancer Hospital (CN), Zhengzhou People's Hospital (CN)
Openalex Percentile: Top 5%
International Maritime Law Issues
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.